Publications by authors named "Thomas Shryock"

Claim this Profile
T
The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings.
Wondwossen A Gebreyes, Jean Dupouy-Camet, Melanie J Newport, Celso J B Oliveira, Larry S Schlesinger, Thomas Shryock

PLoS Negl Trop Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible monensin adaptation in Enterococcus faecium, Enterococcus faecalis and Clostridium perfringens of cattle origin: potential impact on human food safety.
Shabbir Simjee, Anna-Leigh Heffron, Andrew Pridmore, Thomas R Shryock

J Antimicrob Chemother· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals.
Anno de Jong, Valérie Thomas, Shabbir Simjee, Kevin Godinho, Brigitte Schiessl, Thomas R Shryock

J Antimicrob Chemother· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of in vitro minimum inhibitory concentrations of tilmicosin against Mannheimia haemolytica and Pasteurella multocida and in vivo tilmicosin treatment outcome among calves with signs of bovine respiratory disease.
David G McClary, Guy H Loneragan, Thomas R Shryock, Brandon L Carter, Carl A Guthrie

J Am Vet Med Assoc· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the animal health drug development and registration process: an industry perspective.
Robert P Hunter, Thomas R Shryock, Brian R Cox, Roger M Butler, Jason E Hammelman

Future Med Chem· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interface between veterinary and human antibiotic use.
Thomas R Shryock, Amy Richwine

Ann N Y Acad Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrolide-resistant Campylobacter: the meat of the matter.
Aimee E Belanger, Thomas R Shryock

J Antimicrob Chemother· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agar dilution and disk diffusion susceptibility testing of Campylobacter spp.
Thomas R Fritsche, Patrick F McDermott, Thomas R Shryock, Robert D Walker, Teresa Y Morishita

J Clin Microbiol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal health pharmaceutical industry.
Richard A Carnevale, Thomas R Shryock

Prev Vet Med· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internationally recognized antimicrobial susceptibility testing methods and interpretive criteria: the case for conformity.
Thomas R Shryock

J Infect Dis· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The susceptibility to growth-promoting antibiotics of Enterococcus faecium isolates from pigs and chickens in Europe.
Robin Bywater, Malcolm McConville, Ian Phillips, Thomas Shryock

J Antimicrob Chemother· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avilamycin did not play a role in the discontinuation of evernimicin as a clinical drug candidate.
Aimee E Belanger, Thomas R Shryock

J Mass Spectrom· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals.
Robin Bywater, Hubert Deluyker, Erik Deroover, Anno de Jong, Hervé Marion, Thomas Shryock

J Antimicrob Chemother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of anti-infective products in animal health.
Thomas R Shryock

Nat Rev Microbiol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella multocida and Actinobacillus pleuropneumoniae associated with porcine respiratory disease.
Thomas R Shryock, J Mitchell Staples, David C DeRosa

J Vet Diagn Invest· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of a novel capsule-associated lipoprotein among pasteurellaceae pathogenic in animals.
Franklin R Champlin, Thomas R Shryock, Charles E Patterson, Frank W Austin, Phillip E Ryals

Curr Microbiol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis